Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise

NCT03718780
completednot_applicable

Hyperventilation in Patients With Traumatic Brain Injury

NCT03822026
unknownnot_applicable

Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension

NCT03810443

Clinical Trials (3)

Showing 3 of 3 trials
NCT03718780Not Applicable

Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise

Unknown
NCT03822026Not Applicable

Hyperventilation in Patients With Traumatic Brain Injury

Completed
NCT03810443Not Applicable

Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension

Unknown

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3